Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.266 SEK | -5.67% | +5.14% | -12.21% |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Gerward
CEO | Chief Executive Officer | 36 | 01/14/01 |
Mattias Münnich
FOU | Founder | 45 | 01/15/01 |
Thomas Pålsson
DFI | Director of Finance/CFO | 72 | 01/18/01 |
Chief Tech/Sci/R&D Officer | 65 | 01/23/01 | |
Anders Lehmann
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/15/01 |
Sara Richardson
LAW | General Counsel | 53 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 30/21/30 | |
Erik Kinnman
BRD | Director/Board Member | 66 | 01/20/01 |
Ulf Björklund
CHM | Chairman | 68 | 02/21/02 |
Gudrun Anstrén
BRD | Director/Board Member | 69 | 01/21/01 |
Director/Board Member | 49 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,720,903 | 25,587,807 ( 80.67 %) | 0 | 80.67 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-12.21% | 801K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- STABL Stock
- Company Stayble Therapeutics AB